Related Experiment Video

Updated: Jan 29, 2026

New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation
08:45

New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation

Published on: June 27, 2025

1.5K

Predictable and Unusual Adverse Effects of Immunosuppression in Pediatric Liver Transplant Patients

Hakan Öztürk1, Neslihan Ekşi Bozbulut, Sinan Sarı

  • 1From the Department of Pediatric Gastroenterology,Gazi University Faculty of Medicine, Ankara, Turkey.

Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation
|February 20, 2019
PubMed

Insights

Pediatric liver transplant patients can experience various adverse effects from immunosuppression, including common issues like diarrhea and hyperglycemia, as well as rarer complications. Clinicians should consider immunosuppression when evaluating unexpected symptoms in these children.

Area of Science:

  • Pediatric Gastroenterology
  • Transplant Surgery
  • Immunology

Background:

  • Immunosuppressive protocols are crucial after pediatric liver transplantation to prevent organ rejection.
  • Understanding the full spectrum of adverse effects is vital for managing post-transplant complications and improving patient outcomes.

Purpose of the Study:

  • To identify and characterize the potentially adverse effects of immunosuppressive protocols in children following liver transplantation.
  • To highlight both common and unusual adverse events associated with specific immunosuppressive agents.

Main Methods:

  • Retrospective analysis of medical records for 60 pediatric liver transplant recipients.
  • Identification of primary immunosuppressive agents: corticosteroid, tacrolimus, and mycophenolate mofetil.
  • Documentation of observed adverse effects and their potential correlation with specific medications.

Main Results:

  • Common adverse effects included diarrhea (mycophenolate mofetil), hyperglycemia/hypertension (corticosteroid), and seizures/tremors (tacrolimus).
  • Unusual adverse events potentially linked to tacrolimus included hemolytic anemia, eosinophilic gastroenteritis, de novo food allergy, and renal tubular acidosis.
  • Post-transplant lymphoproliferative disorder and acute lymphoblastic lymphoma were also observed.

Conclusions:

  • Adverse effects of immunosuppression significantly contribute to postoperative morbidity in pediatric liver transplant recipients.
  • While common side effects are well-recognized, clinicians must remain vigilant for unexpected symptoms potentially related to immunosuppressive therapy.
  • Prompt recognition and management of both predictable and unusual adverse events are essential for optimizing care in this patient population.
Abstract

More Related Videos

Orthotopic Liver Transplantation in Rats18:25

Orthotopic Liver Transplantation in Rats

Published on: July 1, 2012

31.2K
Liver Cold Storage and Transplantation in the Cold-Adaptive Daurian Ground Squirrels08:37

Liver Cold Storage and Transplantation in the Cold-Adaptive Daurian Ground Squirrels

Published on: July 3, 2025

809

Related Concept Videos

Local Anesthetics: Adverse Effects01:12

Local Anesthetics: Adverse Effects

While local anesthetics are generally safe and well-tolerated, they can occasionally cause adverse effects that vary in severity. Local anesthetics can induce toxicity at two distinct levels. They can either produce local effects through direct contact with the neural elements or be absorbed into the bloodstream from the injection site, leading to systemic effects.
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
796
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
810
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
745
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
225
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
285
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
213